3.17 USD
▲+0.16+4.97%
盘后 3.08 +1.99%
2026-08-03
市值
$303.21M
市盈率
—
EPS
-1.20
股息率
—
52 周区间
2.74 – 8.59
成交量
3.50M
Beta
1.67
目标价
5.34
52W 低 2.7452W 高 8.59
价格走势
公司简介
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion...